| CURRENT STRATEGIES IN STROKE THERAPY: TEMPORALITY, PHARMACOLOGICAL AGENTS AND ENDOVASCULAR TREATMENTS |
|
| Year : 2018 | Volume
: 5
| Issue : 1 | Page : 33-38 |
|
|
Current strategies in stroke therapy: Temporality, pharmacological agents and endovascular treatments
Yunis Mayasi1, Brian Silver2
1 Division of Neurosciences Critical Care, Department of Anesthesia and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA
2 Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA
Correspondence Address:
Brian Silver
Department of Neurology, University of Massachusetts Medical School, 55 Lake Ave, North Worcester, MA 01655
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/astrocyte.astrocyte_49_18
|
|
|
Stroke, a leading cause of morbidity and mortality, remains an active venue for discovery. Advances in stroke neurology include prevention, treatment, and detection, in addition to rehabilitation. In terms of treatment, vast strides have been taken since the five major intra-arterial treatment trials, with extension of the treatment window in addition to the use of imaging for better patient selection. Treatment of hemorrhagic stroke has also improved in the past decade with better understanding of the pathophysiology of the disease, establishment of guidelines for blood pressure control and monitoring, treatment of coagulopathies in addition to surgical interventions. Several ongoing trials are being conducted to further elucidate the utility and efficacy of minimally invasive surgical options in deep intracranial hemorrhage. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
